NCT04971356View on ClinicalTrials.gov

1-month DAPT Plus 5-month Ticagrelor Monotherapy Versus 12-month DAPT in Patients With Drug-coated Balloon

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,948

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

December 1, 2026

Conditions
Antiplatelet DrugAcute Coronary SyndromeAngioplasty, Balloon
Interventions
DRUG

Aspirin 100mg for 1-month (immediately after PCI)

Aspirin for 1-month immediately after PCI to be a part of medication treatment in the Experimental arm

DRUG

Ticagrelor 90mg for 6-month (immediately after PCI)

Ticagrelor for 6-month immediately after PCI to be a part of medication treatment in the Experimental arm

DRUG

Aspirin 100mg for 6-month (6-month post PCI)

Aspirin for 6-month at 6 months post-PCI (after the discontinuation of the 6-month Ticagrelor treatment) to be a part of medication treatment in the Experimental arm

DRUG

Aspirin 100mg for 12-month (immediately after PCI)

Aspirin for 12-month immediately after PCI to be a part of medication treatment in the Reference arm

DRUG

Ticagrelor 90mg for 12-month (immediately after PCI)

Ticagrelor for 12-month immediately after PCI to be a part of medication treatment in the Reference arm

Trial Locations (1)

710032

Ling Tao, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER